Adult Refractory Diffuse Large B-Cell Lymphoma
1 clinical trials · Condition
◉ Watch Adult Refractory Diffuse Large B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| DPX-Survivac and Checkpoint Inhibitor in DLBCL (NCT03349450) | Sunnybrook Health Sciences Centre | 2018-03-13 |
Track Adult Refractory Diffuse Large B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.